Search results
Results from the WOW.Com Content Network
A thymoma is a tumor originating from the epithelial cells of the thymus that is considered a rare neoplasm. [1] Thymomas are frequently associated with neuromuscular disorders such as myasthenia gravis; [2] thymoma is found in 20% of patients with myasthenia gravis. [3] Once diagnosed, thymomas may be removed surgically.
Thymic carcinoma, or type C thymoma, is a malignancy of the thymus. It is a rare cancer that is often diagnosed at advanced stages. Recurrence following treatment is common, and thymic carcinoma is associated with a poor prognosis. [1]
The Journal of the National Comprehensive Cancer Network, established in 2003, is a monthly peer-reviewed medical journal of oncology and the official journal of the National Comprehensive Cancer Network (NCCN). It is published by Harborside Press and the editor-in-chief is Margaret Tempero (UCSF Helen Diller Family Comprehensive Cancer Center ...
Thymic cancer is a general term for a cancer of the thymus gland. Thymic carcinoma; Thymoma This page was last edited on 11 May 2022, at ...
The National Comprehensive Cancer Network (NCCN) is an alliance of 33 [1] cancer centers in the United States, most of which are designated by the National Cancer Institute (one of the U.S. National Institutes of Health) as comprehensive cancer centers. It is a non-profit organization with offices in Plymouth Meeting, Pennsylvania.
Thymectomy is a treatment for myasthenia gravis, a neuromuscular disease. [5] For about 60% of people with myasthenia gravis, thymectomy significantly improves their symptoms of muscle weakness. In about 30% of cases, thymectomy results in permanent remission of myasthenia gravis, negating the need for any additional medication.
In addition to being an NCI-designated comprehensive cancer center, it is a founding member of the National Comprehensive Cancer Network [4] The center’s founding director was Max Wicha, a medical oncologist and researcher who was part of the team to first discover cancer stem cells in a solid tumor. [5] Wicha served as director for 27 years.
Detailed guidelines for managing neuroendocrine tumors are available from ESMO, [76] NCCN [77] and a UK panel. [1] The NCI has guidelines for several categories of NET: islet cell tumors of the pancreas, [ 78 ] gastrointestinal carcinoids, [ 79 ] Merkel cell tumors [ 80 ] and pheochromocytoma / paraganglioma . [ 81 ]